(VIANEWS) – Eagle Point Credit Company (ECC), Reinsurance Group of America (RGA), ACM Research (ACMR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Eagle Point Credit Company (ECC)
28.9% sales growth and 18.54% return on equity
Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC. It invests in fixed income markets of the United States. The fund invests equity and junior debt tranches of collateralized loan obligations consisting primarily of below investment grade U.S. senior secured loans. Eagle Point Credit Company Inc. was formed on March 24, 2014 and is domiciled in the United States.
Earnings Per Share
As for profitability, Eagle Point Credit Company has a trailing twelve months EPS of $1.74.
PE Ratio
Eagle Point Credit Company has a trailing twelve months price to earnings ratio of 5.86. Meaning, the purchaser of the share is investing $5.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.54%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 7, 2024, the estimated forward annual dividend rate is 1.92 and the estimated forward annual dividend yield is 18.71%.
Volume
Today’s last reported volume for Eagle Point Credit Company is 471895 which is 34.24% below its average volume of 717642.
Sales Growth
Eagle Point Credit Company’s sales growth for the next quarter is 28.9%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 21.1%, now sitting on 139.07M for the twelve trailing months.
2. Reinsurance Group of America (RGA)
17.1% sales growth and 10.05% return on equity
Reinsurance Group of America, Incorporated engages in reinsurance business. The company offers individual and group life and health insurance products, such as term life, credit life, universal life, whole life, group life and health, joint and last survivor insurance, critical illness, disability, and longevity products; asset-intensive and financial reinsurance products; and other capital motivated solutions. It also provides reinsurance for mortality, morbidity, lapse, and investment-related risk associated with products; and reinsurance for investment-related risks. In addition, the company develops and markets technology solutions; and provides consulting and outsourcing solutions for the insurance and reinsurance industries. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was founded in 1973 and is headquartered in Chesterfield, Missouri.
Earnings Per Share
As for profitability, Reinsurance Group of America has a trailing twelve months EPS of $13.
PE Ratio
Reinsurance Group of America has a trailing twelve months price to earnings ratio of 16.15. Meaning, the purchaser of the share is investing $16.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.05%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 49.1%, now sitting on 20.65B for the twelve trailing months.
3. ACM Research (ACMR)
15.7% sales growth and 12.26% return on equity
ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers with fine feature sizes; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating. The company markets and sells its products under the Ultra C brand name through direct sales force and third-party representatives. ACM Research, Inc. was incorporated in 1998 and is headquartered in Fremont, California.
Earnings Per Share
As for profitability, ACM Research has a trailing twelve months EPS of $1.31.
PE Ratio
ACM Research has a trailing twelve months price to earnings ratio of 18.02. Meaning, the purchaser of the share is investing $18.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.26%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 27.1% and a negative 21.1%, respectively.
Volume
Today’s last reported volume for ACM Research is 299084 which is 83.04% below its average volume of 1763840.
Moving Average
ACM Research’s worth is way under its 50-day moving average of $27.80 and way above its 200-day moving average of $20.50.
Sales Growth
ACM Research’s sales growth is 41.1% for the present quarter and 15.7% for the next.
4. Intercontinental Exchange (ICE)
15.6% sales growth and 10.29% return on equity
Intercontinental Exchange, Inc., together with its subsidiaries, engages in the provision of market infrastructure, data services, and technology solutions for financial institutions, corporations, and government entities in the United States, the United Kingdom, the European Union, Singapore, India, Abu Dhabi, Israel, and Canada. It operates through three segments: Exchanges, Fixed Income and Data Services, and Mortgage Technology. The company operates regulated marketplaces for listing, trading, and clearing an array of derivatives contracts and financial securities, such as commodities, interest rates, foreign exchange, and equities, as well as corporate and exchange-traded funds; and trading venues, including regulated exchanges and clearing houses. It also offers energy, agricultural and metals, and financial futures and options; and cash equities and equity options, and over-the-counter and other markets, as well as listings and data and connectivity services. In addition, the company provides fixed income data and analytic, fixed income execution, CDS clearing, and other multi-asset class data and network services. Further, it offers proprietary and comprehensive mortgage origination platform, which serves residential mortgage loans; closing solutions that provides customers connectivity to the mortgage supply chain and facilitates the secure exchange of information; data and analytics services; and Data as a Service for lenders to access data and origination information. Intercontinental Exchange, Inc. was founded in 2000 and is headquartered in Atlanta, Georgia.
Earnings Per Share
As for profitability, Intercontinental Exchange has a trailing twelve months EPS of $4.19.
PE Ratio
Intercontinental Exchange has a trailing twelve months price to earnings ratio of 31.87. Meaning, the purchaser of the share is investing $31.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.29%.
5. LeMaitre Vascular (LMAT)
10.4% sales growth and 11.65% return on equity
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers restoreflow allografts; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access in patients with or without a previously-failed synthetic graft; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Earnings Per Share
As for profitability, LeMaitre Vascular has a trailing twelve months EPS of $1.51.
PE Ratio
LeMaitre Vascular has a trailing twelve months price to earnings ratio of 51.24. Meaning, the purchaser of the share is investing $51.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.65%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 30.6% and 27.3%, respectively.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 15, 2024, the estimated forward annual dividend rate is 0.64 and the estimated forward annual dividend yield is 0.81%.
6. PNM Resources (PNM)
9.7% sales growth and 4.11% return on equity
PNM Resources, Inc., through its subsidiaries, provides electricity and electric services in the United States. It operates through Public Service Company of New Mexico (PNM) and Texas-New Mexico Power Company (TNMP) segments. The PNM segment engages in the generation, transmission, and distribution of electricity. The segment owns and leases communication, office and other equipment, office space, vehicles, and real estate. It generates electricity using coal, natural gas and oil, nuclear fuel, solar, wind, and geothermal energy sources. The TNMP segment provides regulated transmission and distribution services. The segment also owns and leases vehicles, service facilities, and office locations throughout its service territory. The company serves residential, commercial, and industrial customers and end-users of electricity in New Mexico and Texas. PNM Resources, Inc. was founded in 1882 and is headquartered in Albuquerque, New Mexico.
Earnings Per Share
As for profitability, PNM Resources has a trailing twelve months EPS of $0.9.
PE Ratio
PNM Resources has a trailing twelve months price to earnings ratio of 41.51. Meaning, the purchaser of the share is investing $41.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.11%.
Moving Average
PNM Resources’s value is higher than its 50-day moving average of $37.25 and under its 200-day moving average of $40.20.
